{"entity":{"type":"insider","cik":"0001892413","url":"/insider/0001892413","json_url":"/insider/0001892413.json","name":"Kuriakose Emil","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":6,"first":"2025-01-06","last":"2026-04-02","span_basis":"filed_date"},"name_variants":[{"name":"Kuriakose Emil","source":"filing","n_filings":6,"first_seen":"2025-01-06","last_seen":"2026-04-02"}],"transactions":[{"id":5997751,"accession":"0001892413-26-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001892413-26-000006","line_url":"/filing/0001892413-26-000006#line-1","is_derivative":false,"issuer_cik":"0001831363","issuer_name":"Terns Pharmaceuticals, Inc.","issuer_ticker":"TERN","issuer_name_source":null,"issuer_url":"/issuer/0001831363","owner_cik":"0001892413","owner_name":"Kuriakose Emil","owner_display_name":"Kuriakose Emil","owner_url":"/insider/0001892413","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":942.0,"shares_display":"942","price_per_share":52.7526,"price_display":"52.75","price_state":"stated","total_value":49692.9492,"total_display":"49,692.95","total_whole":"49,693","shares_owned_after":105673.0,"shares_owned_after_display":"105,673","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-01","filed_date":"2026-04-02","scope":"insider"},{"id":6048068,"accession":"0001892413-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001892413-26-000002","line_url":"/filing/0001892413-26-000002","is_derivative":false,"issuer_cik":"0001831363","issuer_name":"Terns Pharmaceuticals, Inc.","issuer_ticker":"TERN","issuer_name_source":null,"issuer_url":"/issuer/0001831363","owner_cik":"0001892413","owner_name":"Kuriakose Emil","owner_display_name":"Kuriakose Emil","owner_url":"/insider/0001892413","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1155.0,"shares_display":"1,155","price_per_share":38.57356103896104,"price_display":"38.57","price_state":"stated","total_value":44552.463,"total_display":"44,552.46","total_whole":"44,552","shares_owned_after":50365.0,"shares_owned_after_display":"50,365","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-02","filed_date":"2026-01-06","scope":"insider","n_lines":2},{"id":4562540,"accession":"0001892413-25-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001892413-25-000004","line_url":"/filing/0001892413-25-000004#line-1","is_derivative":false,"issuer_cik":"0001831363","issuer_name":"Terns Pharmaceuticals, Inc.","issuer_ticker":"TERN","issuer_name_source":null,"issuer_url":"/issuer/0001831363","owner_cik":"0001892413","owner_name":"Kuriakose Emil","owner_display_name":"Kuriakose Emil","owner_url":"/insider/0001892413","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":944.0,"shares_display":"944","price_per_share":7.8464,"price_display":"7.85","price_state":"stated","total_value":7407.0016,"total_display":"7,407.00","total_whole":"7,407","shares_owned_after":51520.0,"shares_owned_after_display":"51,520","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-01","filed_date":"2025-10-02","scope":"insider"},{"id":4599238,"accession":"0001562180-25-005308","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-25-005308","line_url":"/filing/0001562180-25-005308#line-1","is_derivative":false,"issuer_cik":"0001831363","issuer_name":"Terns Pharmaceuticals, Inc.","issuer_ticker":"TERN","issuer_name_source":null,"issuer_url":"/issuer/0001831363","owner_cik":"0001892413","owner_name":"Kuriakose Emil","owner_display_name":"Kuriakose Emil","owner_url":"/insider/0001892413","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":853.0,"shares_display":"853","price_per_share":4.2671,"price_display":"4.27","price_state":"stated","total_value":3639.8363,"total_display":"3,639.84","total_whole":"3,640","shares_owned_after":52464.0,"shares_owned_after_display":"52,464","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-01","filed_date":"2025-07-03","scope":"insider"},{"id":4926992,"accession":"0001562180-25-002920","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-25-002920","line_url":"/filing/0001562180-25-002920#line-1","is_derivative":false,"issuer_cik":"0001831363","issuer_name":"Terns Pharmaceuticals, Inc.","issuer_ticker":"TERN","issuer_name_source":null,"issuer_url":"/issuer/0001831363","owner_cik":"0001892413","owner_name":"Kuriakose Emil","owner_display_name":"Kuriakose Emil","owner_url":"/insider/0001892413","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":952.0,"shares_display":"952","price_per_share":2.4851,"price_display":"2.49","price_state":"stated","total_value":2365.8152,"total_display":"2,365.82","total_whole":"2,366","shares_owned_after":53317.0,"shares_owned_after_display":"53,317","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-01","filed_date":"2025-04-02","scope":"insider"},{"id":4041222,"accession":"0001562180-25-000221","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-25-000221","line_url":"/filing/0001562180-25-000221#line-1","is_derivative":false,"issuer_cik":"0001831363","issuer_name":"Terns Pharmaceuticals, Inc.","issuer_ticker":"TERN","issuer_name_source":null,"issuer_url":"/issuer/0001831363","owner_cik":"0001892413","owner_name":"Kuriakose Emil","owner_display_name":"Kuriakose Emil","owner_url":"/insider/0001892413","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4481.0,"shares_display":"4,481","price_per_share":5.7146,"price_display":"5.71","price_state":"stated","total_value":25607.1226,"total_display":"25,607.12","total_whole":"25,607","shares_owned_after":54269.0,"shares_owned_after_display":"54,269","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-02","filed_date":"2025-01-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001831363","name":"Terns Pharmaceuticals, Inc.","url":"/issuer/0001831363","role":"Officer (Chief Medical Officer)","n_filings":6,"first_seen":"2025-01-06","last_seen":"2026-04-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001892413","retrieved_at":"2026-08-23T00:33:39+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}